Overexpression of SOX1 subsequently decreased expression of β-catenin and suppressed the Wnt/β-catenin signaling pathway, thereby reversing the malignant phenotype of NPC cells. This evidence concerns the gene SOX1 and nasopharyngeal carcinoma.